logo

Novus Therapeutics, Inc. (NVUS)



Trade NVUS now with
  Date
  Headline
6/19/2018 7:34:29 AM Novus Therapeutics Gets FDA Guidance At Type C Meeting For OP-02 In The Treatment And Prevention Of Otitis Media
5/11/2018 9:20:30 AM Novus Therapeutics Q1 Net Loss Of $2.8 Mln Or $0.36/shr Vs. Net Loss Of $1.4 Mln Or $0.59/shr Prior Year
4/2/2018 9:04:48 AM Novus Therapeutics Q4 Net Loss $2.1 Mln Or $0.30/shr Vs. Loss Of $1.5 Mln Or $0.57/shr Prior Year